Phuong N. Huynh

Array ( [id] => 787957 [patent_doc_number] => 06986888 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-17 [patent_title] => 'Method for treating mammals with modified mammalian blood' [patent_app_type] => utility [patent_app_number] => 09/564583 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 7678 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/986/06986888.pdf [firstpage_image] =>[orig_patent_app_number] => 09564583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 875378 [patent_doc_number] => 07357930 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-04-15 [patent_title] => 'Methods and formulations for targeting infectious agents bearing host cell proteins' [patent_app_type] => utility [patent_app_number] => 09/980516 [patent_app_country] => US [patent_app_date] => 2000-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 10993 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/357/07357930.pdf [firstpage_image] =>[orig_patent_app_number] => 09980516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1246251 [patent_doc_number] => 06677437 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Serine-threonine kinase gene' [patent_app_type] => B1 [patent_app_number] => 09/563997 [patent_app_country] => US [patent_app_date] => 2000-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 13360 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677437.pdf [firstpage_image] =>[orig_patent_app_number] => 09563997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1574334 [patent_doc_number] => 06468750 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Cell regulation factor TTO 20' [patent_app_type] => B1 [patent_app_number] => 09/561989 [patent_app_country] => US [patent_app_date] => 2000-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6124 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468750.pdf [firstpage_image] =>[orig_patent_app_number] => 09561989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1453192 [patent_doc_number] => 06461821 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor' [patent_app_type] => B1 [patent_app_number] => 09/530423 [patent_app_country] => US [patent_app_date] => 2000-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10660 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/461/06461821.pdf [firstpage_image] =>[orig_patent_app_number] => 09530423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1489230 [patent_doc_number] => 06416758 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Antibody conjugate kits for selectively inhibiting VEGF' [patent_app_type] => B1 [patent_app_number] => 09/561526 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 92113 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/416/06416758.pdf [firstpage_image] =>[orig_patent_app_number] => 09561526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493341 [patent_doc_number] => 06342221 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Antibody conjugate compositions for selectively inhibiting VEGF' [patent_app_type] => B1 [patent_app_number] => 09/561108 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 92070 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342221.pdf [firstpage_image] =>[orig_patent_app_number] => 09561108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1406230 [patent_doc_number] => 06524583 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Antibody methods for selectively inhibiting VEGF' [patent_app_type] => B1 [patent_app_number] => 09/561499 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 92114 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524583.pdf [firstpage_image] =>[orig_patent_app_number] => 09561499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493332 [patent_doc_number] => 06342219 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Antibody compositions for selectively inhibiting VEGF' [patent_app_type] => B1 [patent_app_number] => 09/561500 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 92127 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342219.pdf [firstpage_image] =>[orig_patent_app_number] => 09561500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1489911 [patent_doc_number] => 06416977 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Flea chitinase nucleic acid molecules and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/545814 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37210 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/416/06416977.pdf [firstpage_image] =>[orig_patent_app_number] => 09545814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82619 [patent_doc_number] => 07740841 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-06-22 [patent_title] => 'Therapeutic method for reducing angiogenesis' [patent_app_type] => utility [patent_app_number] => 09/539692 [patent_app_country] => US [patent_app_date] => 2000-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 10894 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/740/07740841.pdf [firstpage_image] =>[orig_patent_app_number] => 09539692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056097 [patent_doc_number] => 06855320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-15 [patent_title] => 'Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity' [patent_app_type] => utility [patent_app_number] => 09/537642 [patent_app_country] => US [patent_app_date] => 2000-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3355 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855320.pdf [firstpage_image] =>[orig_patent_app_number] => 09537642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1403807 [patent_doc_number] => 06528060 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Therapeutic compounds' [patent_app_type] => B1 [patent_app_number] => 09/527487 [patent_app_country] => US [patent_app_date] => 2000-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21079 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528060.pdf [firstpage_image] =>[orig_patent_app_number] => 09527487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6330843 [patent_doc_number] => 20020198364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Chimeric contraceptive vaccines' [patent_app_type] => new [patent_app_number] => 09/524974 [patent_app_country] => US [patent_app_date] => 2000-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5311 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20020198364.pdf [firstpage_image] =>[orig_patent_app_number] => 09524974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 776685 [patent_doc_number] => 06998108 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-14 [patent_title] => 'Antibodies to p30 polypeptides and methods making and using same' [patent_app_type] => utility [patent_app_number] => 09/524325 [patent_app_country] => US [patent_app_date] => 2000-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 13505 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998108.pdf [firstpage_image] =>[orig_patent_app_number] => 09524325 [rel_patent_id] =>[rel_patent_doc_number] =>)